Fusarium species central nervous system infection

• Published in: Current opinion in infectious diseases Vol. 37; no. 3; pp. 185 - 191
• Main Authors: Strong, Nora, Ostrosky-Zeichner, Luis
• Format: Journal Article
• Language: English
• Published: United States 01-06-2024
• Subjects: Antifungal Agents - therapeutic use; Central Nervous System Fungal Infections - diagnosis; Central Nervous System Fungal Infections - drug therapy; Central Nervous System Fungal Infections - microbiology; Fusariosis - diagnosis; Fusariosis - drug therapy; Fusariosis - microbiology; Fusarium - drug effects; Humans; Immunocompromised Host; Incidence
• ISSN: 0951-7375; 1473-6527
• DOI: 10.1097/QCO.0000000000001009

Fusarium species are an increasingly important cause of meningitis and invasive disease in immunocompromised patients as well as in otherwise healthy patients as observed in two recent healthcare-associated outbreaks. This review summarizes recently published information on treatment and diagnosis of this infection.
Incidence of Fusarium species meningitis and invasive fusariosis are increasing. Molecular techniques are improving the speed of diagnosis. New antifungal agents in development show good in vitro activity against some Fusarium species. New technologies, including cerebrospinal fluid (CSF) filtration, may play a role in treatment of central nervous system (CNS) disease. Due to the continued prime importance of the host immune system in recovery, immunomodulatory treatments may play a role in treatment.
The overall incidence of CNS fusariosis is increasing with a continued poor prognosis, but new diagnostic and treatment modalities are in development which may offer improvements.